A Phase IIb Trial Assessing the Addition of Disulfiram to Chemotherapy for the Treatment of Metastatic Non-Small Cell Lung Cancer

BACKGROUND. Disulfiram, an alcohol aversion agent, has been in use for >50 years. Numerous authors have reported an anticancer effect of this drug in vitro and in mouse models. More recently, several reports have claimed that disulfiram also possesses anti-stem cell activity. We set out to obtain...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:Oncologist
Asıl Yazarlar: Nechushtan, Hovav, Hamamreh, Yousef, Nidal, Salim, Gotfried, Maya, Baron, Amichai, Shalev, Yossi Israeli, Nisman, Benjjamin, Peretz, Tamar, Peylan-Ramu, Nili
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: AlphaMed Press 2015
Konular:
Clinical Trial Results
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC4391770/
https://ncbi.nlm.nih.gov/pubmed/25777347
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1634/theoncologist.2014-0424
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller